Q4 results of Smith&Nephew, NuVASIVE

  • Spine bussiness is meeting solid milestones


  • Smith & Nephew, new leadership resulted in 7 % rise in stock


  • NuVasive expected to grow 4 - 6 % in 2020


Read more


source: Medtechdive